Cargando…

How I faced my prostate cancer: a molecular biologist’s perspective

Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuradelli, Monica, Lazzeri, Massimo, Lopci, Egesta, Zucali, Paolo Andrea, Balzarini, Luca, Guazzoni, Giorgio, Colombo, Piergiuseppe, Scorsetti, Marta, Franzese, Ciro, Asselta, Rosanna, Soldà, Giulia, Duga, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463686/
https://www.ncbi.nlm.nih.gov/pubmed/34561542
http://dx.doi.org/10.1038/s41698-021-00229-5
_version_ 1784572447889031168
author Zuradelli, Monica
Lazzeri, Massimo
Lopci, Egesta
Zucali, Paolo Andrea
Balzarini, Luca
Guazzoni, Giorgio
Colombo, Piergiuseppe
Scorsetti, Marta
Franzese, Ciro
Asselta, Rosanna
Soldà, Giulia
Duga, Stefano
author_facet Zuradelli, Monica
Lazzeri, Massimo
Lopci, Egesta
Zucali, Paolo Andrea
Balzarini, Luca
Guazzoni, Giorgio
Colombo, Piergiuseppe
Scorsetti, Marta
Franzese, Ciro
Asselta, Rosanna
Soldà, Giulia
Duga, Stefano
author_sort Zuradelli, Monica
collection PubMed
description Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling.
format Online
Article
Text
id pubmed-8463686
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84636862021-10-08 How I faced my prostate cancer: a molecular biologist’s perspective Zuradelli, Monica Lazzeri, Massimo Lopci, Egesta Zucali, Paolo Andrea Balzarini, Luca Guazzoni, Giorgio Colombo, Piergiuseppe Scorsetti, Marta Franzese, Ciro Asselta, Rosanna Soldà, Giulia Duga, Stefano NPJ Precis Oncol Comment Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling. Nature Publishing Group UK 2021-09-24 /pmc/articles/PMC8463686/ /pubmed/34561542 http://dx.doi.org/10.1038/s41698-021-00229-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Zuradelli, Monica
Lazzeri, Massimo
Lopci, Egesta
Zucali, Paolo Andrea
Balzarini, Luca
Guazzoni, Giorgio
Colombo, Piergiuseppe
Scorsetti, Marta
Franzese, Ciro
Asselta, Rosanna
Soldà, Giulia
Duga, Stefano
How I faced my prostate cancer: a molecular biologist’s perspective
title How I faced my prostate cancer: a molecular biologist’s perspective
title_full How I faced my prostate cancer: a molecular biologist’s perspective
title_fullStr How I faced my prostate cancer: a molecular biologist’s perspective
title_full_unstemmed How I faced my prostate cancer: a molecular biologist’s perspective
title_short How I faced my prostate cancer: a molecular biologist’s perspective
title_sort how i faced my prostate cancer: a molecular biologist’s perspective
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463686/
https://www.ncbi.nlm.nih.gov/pubmed/34561542
http://dx.doi.org/10.1038/s41698-021-00229-5
work_keys_str_mv AT zuradellimonica howifacedmyprostatecanceramolecularbiologistsperspective
AT lazzerimassimo howifacedmyprostatecanceramolecularbiologistsperspective
AT lopciegesta howifacedmyprostatecanceramolecularbiologistsperspective
AT zucalipaoloandrea howifacedmyprostatecanceramolecularbiologistsperspective
AT balzariniluca howifacedmyprostatecanceramolecularbiologistsperspective
AT guazzonigiorgio howifacedmyprostatecanceramolecularbiologistsperspective
AT colombopiergiuseppe howifacedmyprostatecanceramolecularbiologistsperspective
AT scorsettimarta howifacedmyprostatecanceramolecularbiologistsperspective
AT franzeseciro howifacedmyprostatecanceramolecularbiologistsperspective
AT asseltarosanna howifacedmyprostatecanceramolecularbiologistsperspective
AT soldagiulia howifacedmyprostatecanceramolecularbiologistsperspective
AT dugastefano howifacedmyprostatecanceramolecularbiologistsperspective